News Hub | News Direct


Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Industrial Defender Named Hot Company in OT Vulnerability Management by Cyber Defense Magazine in the Global InfoSec Awards

Industrial Defender

Industrial Defender, an operational technology (OT) security pioneer, announced that it has received the “Hot Company in Operational Technology Vulnerability Management” award from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine.For this awards program, CDM seeks out next-generation players with new, unique technologies, rather than the ones with the most customers or money in the bank. The judges are CISSP, FMDHS, CEH, certified security professionals who voted based on their independent review of each company’s submission. “Orchestrating OEM vulnerability and patch management in OT environments is a real pain point for industrial companies,” said Jim Crowley, CEO of Industrial Defender. “Our team has worked hard to create an innovative solution to this problem, and we’re thrilled that this panel of leading cybersecurity experts from around the globe has recognized our efforts.” “Industrial Defender embodies three major features we judges look for to become winners: understanding tomorrow’s threats, today, providing a cost-effective solution and innovating in unexpected ways that can help stop the next breach,” said Gary S. Miliefsky, Publisher of Cyber Defense Magazine. All winners of the 9th Annual Global InfoSec Awards will be announced today at RSAC 2021. View the complete list of award winners here: To learn more about Industrial Defender’s OT vulnerability and patch management offering, visit their website: About Industrial Defender Since 2006, Industrial Defender has been solving the challenge of safely collecting, monitoring, and managing OT asset data at scale, while providing cross-functional teams with a unified view of security. Their specialized solution is tailored to complex industrial control system environments by engineers with decades of hands-on OT experience. Easy integrations into the broader security and enterprise ecosystem empower IT teams with the same visibility, access, and situational awareness that they’re accustomed to on corporate networks. Learn more at About CDM InfoSec Awards This is Cyber Defense Magazine’s ninth year of honoring global InfoSec innovators. Our submission requirements are for any startup, early stage, later stage or public companies in the INFORMATION SECURITY (INFOSEC) space who believe they have a unique and compelling value proposition for their product or service. Learn more at About Cyber Defense Magazine With over 5 Million monthly readers and growing, and thousands of pages of searchable online infosec content, Cyber Defense Magazine is the premier source of IT Security information for B2B and B2G with our sister magazine Cyber Security Magazine for B2C. We are managed and published by and for ethical, honest, passionate information security professionals. Our mission is to share cutting-edge knowledge, real-world stories and awards on the best ideas, products and services in the information technology industry. We deliver electronic magazines every month online for free, and special editions exclusively for the RSA Conferences. CDM is a proud member of the Cyber Defense Media Group. Learn more about us at and visit and to see and hear some of the most informative interviews of many of these winning company executives. Join a webinar at and realize that infosec knowledge is power. Contact Details Industrial Defender Erin Anderson +1 617-675-4206 Cyber Defense Magazine April Palanca +16465869545 Company Website

May 17, 2021 12:00 PM Eastern Daylight Time

Article thumbnail News Release

ZIPPZ Introduces Science-Backed, Personalized CBD Products for Sleep and Anxiousness


With a majority of adults suffering from lack of sleep and high levels of stress, it’s time to make some changes. Launching today, ZIPPZ Inc. offers personalized CBD therapies rooted in science and developed by a team of leading physicians and clinicians. Designed to address challenges with sleep, stress, and anxiousness, these patent-pending products provide personalized solutions to fit the unique needs of each individual customer. “The medicinal cannabis industry often defaults to ‘one-size-fits-all’ product solutions, especially when it comes to CBD. On my personal journey to reduce stress, I was shocked by the lack of scientifically-formulated products in the category,” stated Scott Eagle, CEO of ZIPPZ. “ZIPPZ recognizes that each customer is unique, so we developed an innovative program to help consumers get matched to the ZIPPZ CBD wellness formulas customized to meet their specific needs.” Taking a science-first approach, ZIPPZ worked with experts in the fields of medicinal cannabis and bio/botanical research to develop products based on a network pharmacology model. ZIPPZ formulas include a distinct blend of 35 natural ingredients - including CBD, CBN, and CBG plus a selection of proven botanicals (e.g. Ashwagandha, Chamomile, Magnolia Bark) - that target not just one, but multiple receptors in the body that help regulate sleep, stress, and anxiousness. As part of their personalization process, ZIPPZ offers 255 different trial pack combinations for consumers to sample to ensure a customized fit. Dr. June Chin, Integrative Cannabis Physician, author, and advisor for ZIPPZ, stated "I have advocated for the understanding of the medical applications of cannabis my entire career, and I’m a strong believer in CBD’s ability to deliver relief. Over the past 20 years, I’ve helped thousands of patients discover customized cannabis solutions and I’m honored to work with the ZIPPZ team to help them create affordable, personalized CBD therapies that utilize cannabinoids and botanicals to deliver targeted relief to those who need it.” The ZIPPZ approach is data-driven and customer-focused. Prior to purchase, consumers take a 5-minute assessment that analyzes a variety of factors including condition, age, lifestyle, and gender. Based on the assessment results, ZIPPZ creates a customized trial pack of up to four formulas to test as well as a personalized report detailing why each product was recommended. Once the customer receives their trial pack, they can sample each product and make a final determination of which formulas worked best for them. In a recent 3rd party market research study, 89% of people completing their trial of ZIPPZ products found at least one of the recommended products met their needs. ZIPPZ Trial Packs start at $29 and include 5 doses of each recommended formula for the customer to try. Once the best products are identified by the consumer, ZIPPZ credits 100% of the Trial Pack cost towards the purchase of their first full-size bottle. Full-size bottles (60 softgels, 30 doses) start at $78. ZIPPZ products are available exclusively online at To stay informed about everything ZIPPZ, follow them on social at @zippzwellness. ABOUT ZIPPZ: ZIPPZ is a direct-to-consumer, California-based CBD wellness company offering personalized, scientifically-formulated CBD solutions targeting sleep, stress, and anxiousness. Founded by a team of physicians, clinicians, scientists, and technologists, ZIPPZ dismisses the one-size-fits-all approach to CBD therapies. After consumers complete a quick and thorough 5-minute assessment, ZIPPZ uses data science to help match them with personalized solutions. Rooted in nature and activated by science, ZIPPZ combines CBD with over 30 carefully selected botanicals to deliver therapies customized to each individual’s needs. A leader in the revolution of personalized CBD therapies, ZIPPZ offers over 255 combinations of products that provide fast and effective relief. Contact Details Jive PR + Digital Jacki St. Thomas +1 310-625-7799 Company Website

May 17, 2021 06:00 AM Pacific Daylight Time

Article thumbnail News Release

Kreyol Passion Launches Brand and Announces Kickstarter Campaign

Kreyol Passion

We can all agree on one thing, we all love food! Food is universal to everyone, no matter the race or culture. Today, Kreyol Passion launched its brand along with a Kickstarter campaign. Kreyol Passion is built around a human centric approach to fit everyday life styles, enhancing and educating the palate with fresh ingredients and flavors, providing healthy solutions for every cuisine. KP Marinade is the first product roll-out under the Kreyol Passion brand. With only 15 calories per serving KP is used to marinate meats and seafood, grilling, air frying, stir-fry, cooking stews, soups, rice and as a condiment for a variety of foods. No matter the continent or cuisine KP enhances the flavor of food, alleviates the guesswork out of cooking and cuts prep time by 90 percent. Jacques Absolu aims to provide solutions with each idea he brings into the atmosphere and Kreyol Passion is no different. Awaken your Senses & Activate your taste buds! Become Part of our Story! ABOUT THE FOUNDER Kreyol Passion is a Food Distribution Company that is a subsidiary under GGSUCCESS LLC; founded by Jacques Absolu a young Haitian American, tech savvy entrepreneur who has many notable ventures; GGSUCCESS LLC a holding company that focuses on cutting-edge developments in Technology, Finance and Real Estate. Contact Details Kreyol Passion Danielle Lampron +1 561-335-8223 Company Website

May 17, 2021 08:05 AM Eastern Daylight Time

Article thumbnail News Release

Airports, Take Notice: 84% of Travelers Want Bio-Security Measures to Protect Against Current & Future Pandemics


TEL AVIV, Israel, May 17, 2021 –– Ever stop to think how many hands touch your luggage from the time you leave home, arrive at the airport, and then reach your travel destination? Curious to know how many virus particles fit on a single pinhead? Are you in the habit of disinfecting your luggage after a trip? According to a Post-COVID-19 Air Travel/Bio-Security survey conducted last week, all respondents said they believe their baggage has passed through a lot of hands – 10 or more. Of those, 17 percent believe more than 20 hands have handled their luggage, whether while using a ride service, the baggage handlers at the airport, or hotel personnel. It's no wonder, then, that when COVID-19 hit, consumers were reluctant to travel. More than 55 percent of the consumers who completed the survey, in fact, said they did not travel by air last year because they feared either contracting the virus or potentially spreading it to others. This, and the actions taken by the airline industry as a result of COVID-19, created a huge blow to air travel. According to the International Air Transport Association (IATA), the pandemic resulted in a 66 percent drop in air travel last year. That’s more than after the September 11, 2001 terrorist attacks, the Severe Acute Respiratory Syndrome (SARS) outbreak of 2003, and the global financial crisis of 2008. As people around the globe are being vaccinated against the Coronavirus and with more awareness about the devastating effects of virus spread, it’s not surprising that more than 84 percent of respondents said they agree with officials at the world’s leading agencies – the Centers for Disease Control (CDC), World Health Organization (WHO), and the Council of European Unions – that another pandemic is inevitable, and it is critical to be prepared. As with x-ray and other measures taken at airports following the 9/11 terrorist attacks, those same respondents agree airports should take bio-security measures to minimize the health and economic impact of future virus spread. Specifically, when asked if they’d feel safer and more likely to travel by air if luggage would be completely and quickly disinfected using ultraviolet (UV) technology at the airport, 78 percent said yes. For some respondents, the COVID-19 crisis is waning because many have received vaccinations against Coronavirus. Still, only 16 percent said they felt additional bio-security measures are unnecessary. “The COVID-19 virus has inflicted devastating health and economic impact on the world, but the call for bio-security at airports is a practical solution that can lessen or even stop the rapid spread of future contagions,” said Amir Fischer, CEO of WarpUV. “Studies show the most effective way to disinfect items like checked luggage and carry-on bags – many of which are soft-sided or have many handles, zippers and uneven surfaces – is with 360-degree ultraviolet (UV) light bio cleansing. The technology exists, it’s proven fast and effective, and is ready to be implemented.” Some additional data from the WarpUV/SurveyMonkey consumer survey include: When asked whether they realized that 100 million virus particles of COVID-19 could fit on the head of a pin, 62 percent said they had not previously heard that fact. 58 percent of respondents said they have never disinfected their own luggage during or after use. Of those, 28 percent said, in light of the virus spread, they will now start doing so. During the height of the pandemic, the ability to travel by air around the world was heavily curtailed due to flight cancellations, as well as airport closures because baggage handlers or passengers had contracted COVID-19. Just last week, Changi Airport in Si ngapore closed due to a report of COVID-19 cases. Although cases of COVID-19 contracted at airports were widely reported, 55 percent of respondents queried in the survey were unaware of this fact. About WarpUV Warp Technologies and its AirFort® devices are the frontline of prevention of the spread of pandemic by luggage and baggage in airports worldwide and serve as a “disinfection firewall” for continents, countries, and regions. The company was formed in 2020 by veteran Israeli entrepreneurs Amir Fischer, Eitan Haimovich, and Gil Luxenbourg. For more information, visit Contact Details Rainier Communications Joanne Stanway +1 978-273-1473 Rainier Communications Alan Ryan +15085776635 Company Website

May 17, 2021 08:01 AM Eastern Daylight Time

Article thumbnail News Release

Centre for Neuro Skills Promotes Dr. Matthew Ashley to Chief Medical Officer

Centre for Neuro Skills

Centre for Neuro Skills (CNS), a premier provider of traumatic and acquired brain injury rehabilitation services, today announced the promotion of Dr. Matthew Ashley to Chief Medical Officer, overseeing all CNS medical staff. Dr. Ashley will be moving from CNS headquarters in Bakersfield to the new CNS clinic in Austin, Texas, in June. The 17,000 square ft. facility will serve as many as 60 patients and is located at 14425 Falconhead Blvd. "We are thrilled to announce this milestone promotion for Dr. Ashley, who is transitioning to a corporate leadership position overseeing medical departments across all CNS locations,” said David Harrington, President and COO of Centre for Neuro Skills. “His vision and strategic administration will provide uniformity of care across all seven CNS locations. He will continue to work closely with various partners, providers, payers and customers.” During Dr. Ashley’s seven-year tenure at CNS, he has served as a consulting neurologist. He treats a diverse spectrum of patients recovering from traumatic and acquired brain injury. An accomplished speaker, Dr. Ashley lectures at universities and seminars focusing on stroke, epilepsy, dementia, neuroradiology and brain injury rehabilitation. Dr. Ashley received both his medical and juris doctor degrees from Southern Illinois University. He completed a neurology residency at UCLA, as well as a neurological rehabilitation fellowship at the university’s renowned Neurological Rehabilitation and Research Unit. The new Austin location will be CNS’ fourth clinic in Texas, joining others in Dallas, Fort Worth and Houston. CNS also has three California clinics in Los Angeles, San Francisco and Bakersfield. All CNS clinics offer rehabilitation therapies through inpatient, outpatient, day treatment, residential rehabilitation and telehealth technology. "I look forward to my family’s move to Austin, getting to know our new community and my expanded role leading all medical teams across Centre of Neuro Skills’ clinics,” said Dr. Ashley. “The dedication to our patients combined with our continuum of care approach is more critical now than ever - to help those who have suffered from traumatic brain injuries, strokes and, more recently, Long-Haul COVID.” Facts about Brain Injury and Long-Haul COVID The Centre of Neuro Skills provides rehabilitation therapy to traumatic brain injury (TBI), stroke and Long-Haul COVID patients. These affect millions of Americans each year. Traumatic Brain Injury According to the Centers for Disease Control and Prevention (CDC), TBI is a leading cause of death and disability among children and young adults in the US. Each year an estimated 1.5 million Americans sustain a TBI. These injuries result in: 230,000 people are hospitalized and survive 50,000 people die 80,000 to 90,000 people experience the onset of long-term disability As the cumulative result of past traumatic brain injuries, an estimated 5.3 million men, women and children are living with a permanent TBI-related disability in the US today. Stroke According to the CDC, more than 795,000 people in the US have a stroke each year. Someone in the US has a stroke every 40 seconds Stroke is a leading cause of serious long-term disability Stroke reduces mobility in more than half of stroke survivors aged 65 and over Strokes can occur at any age - in 2009, 34% of people hospitalized for stroke were less than 65 years old Land-Haul COVID In a recent University of Washington study, 30% of Long-Haul COVID research participants reported worse health and quality of life, compared to how they felt before their infection. Additionally, 8% said they weren’t able to carry out daily chores. This included not being able to lift heavy objects or stand or walk unassisted for more than a short period of time. The proportion of participants reporting lingering symptoms increased with age. They affected about 27% of those 18 to 36 years old, 30% of those 37 to 64 and 43% of those 65 and older. About Centre for Neuro Skills Centre for Neuro Skills is an experienced and respected world leader in providing intensive rehabilitation and medical programs for those recovering from all types of brain injury. CNS covers a full spectrum of advanced care from residential and assisted living to outpatient/day treatment. Founded by Dr. Mark Ashley in 1980, CNS has seven locations in California and Texas. For more information about Center for Neuro Skills, visit:, Facebook, Twitter, LinkedIn, YouTube. For a video overview of CNS, visit: Media please note: Visual assets, including photos, are available. To request an interview with Dr. Matthew Ashley, please contact Robin Carr at (415) 971-3991 or Contact Details Landis Communications Inc. Robin Carr +1 415-971-3991 Company Website

May 14, 2021 09:32 AM Pacific Daylight Time

Article thumbnail News Release

New Report by Gennev Shows Gaps in Support for Women’s Health and Why It’s Time to Rethink Menopause


A video accompanying this announcement is available at: Every woman will go through menopause—that’s an estimated 1.3 million women in the U.S. alone who enter menopause every year, yet the topic of menopause is still taboo. Women feel confused about what’s normal, uncomfortable talking about it, and unprepared to manage “the change.” With conversations around fertility becoming more open, menopause still feels like a secret, and that leads to misinformation and a significant reduction in quality of life for too many women. To demystify menopause Gennev created the first-of-its kind Menopause NOW Report with 120,000 women who shared information about their lives and health over the past year. The report offers unparalleled insight into how women are experiencing menopause, with findings that show: 70% of women reported putting off preventative health appointments in the past year because of the pandemic 49% reported using telehealth for menopause care 92% reported more stress on top of menopause-related anxiety in the past year Founded and led by women, Gennev is a Seattle-based digital health platform that offers holistic and comprehensive support for women in all stages of menopause. They offer women a virtual clinic with OBGYNs and health coaches on staff, in addition to educational services, community, and wellness products. The results of this year's Menopause NOW report demonstrate women’s need for more comprehensive support from specialized doctors, health coaches, and their fellow women – services all provided by Gennev. Take your personal menopause assessment at, join the #IAmTheChange movement, and become part of the largest menopause community online. Watch Gennev’s video of women sharing their stories, then add your own voice. Click here to watch: About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727

May 14, 2021 09:00 AM Eastern Daylight Time

Article thumbnail News Release



The 4 th Annual Leaders in Life Sciences breakfast roundtable will take place at 7:00AM – 9:00AM EST on May 18, 2021, hosted by LevLane, Boston Healthcare Associates, and Buchanan Ingersoll & Rooney. Select healthcare business leaders will participate in a two-hour virtual roundtable discussion moderated by Stephen K. Klasko, M.D., M.B.A., President and CEO, Thomas Jefferson University and Jefferson Health. Topics will include insights to driving innovation, stakeholder perspectives, investment opportunities, and challenges relating to the future of digital healthcare. The goal of the roundtable is to have an interactive session where panelists can share meaningful insights and learnings with each other. Following the meeting, the discussion’s key insights, learnings, and implications will be summarized and shared with industry entities, as well as other key insight communications. “This event has been successful in years past and we’re excited for this year’s discussion given historic structural changes in healthcare delivery that we have observed over the last 15 months. It’s more important than ever to stay connected, for us as industry leaders and for policymakers, providers and consumers,” said Thomas Goss, PharmD, Senior Vice President, Boston Healthcare Associates. Edward Allera, Shareholder, Buchanan, Ingersoll & Rooney PC, agrees. “It’s beneficial for so many to produce meaningful collaborations when it comes to institutions, services, products, innovations and research. I’m happy to help create a platform to make this possible,” said Allera. Panelists will include: Amy Abernethy, M.D., Ph.D., Former Principal Deputy Commissioner & Acting CIO, FDA Tom Cassels, M.P.P, President, Rock Health Quinn Dufurrena, DDS, JD, Chief Dental Officer of United Concordia Dental Mark Haig Khachaturian, Ph.D., Chief Technology Officer, Wellvii Allison Oelschlaeger, BSFS, Director & Chief Data Officer, CMS Christopher T. Olivia, MD, Chief Executive Officer, Rothman Orthopaedic Institute Samantha (Mandy) J. Pulliam, MD, Chief Medical Officer, Renovia, Inc. Wendy Sanhai, Ph.D., M.B.A., Specialist Leader, Deloitte Consulting, FDA Richard Schwabacher, Senior Vice President of Digital Health and Chief Digital Officer, BioReference Laboratories, Inc. Michael Sherman, MD, M.B.A., Executive Vice President & Chief Medical Officer, Harvard Pilgrim Health Care and Tufts Health Plan “There’s so much talent and many bright minds in the life sciences industry. It’s crucial to bring this group together and give them the opportunity to share knowledge and introduce insights to their peers on a regular basis,“ said Timmy Garde, Chief Innovation Leader, LevLane. Attendance to the 4 th Annual Leaders in Life Sciences Breakfast Roundtable is limited. Please register at: Key insights will be released following the roundtable discussion. About Leaders in Life Sciences Leaders in Life Sciences is a partnership of LevLane, Boston Healthcare, and Buchanan, Ingersoll & Rooney PC. The group was formed to bring together thought leaders in the Life Science space to provide insights and solutions to the biggest challenges facing the industry. To learn more about Leaders in Life Sciences contact Timmy Garde at, Edward Allera at, or Thomas Goss at Contact Details Liz Weir +1 610-401-4825 Company Website

May 14, 2021 07:01 AM Eastern Daylight Time

Article thumbnail News Release


Society of Urologic Oncology

The Society of Urologic Oncology (SUO) is sharing several new valuable resources for patients suffering from malignant genitourinary diseases like bladder cancer, and their caregivers. This release of a guidebook, documentary video, and public service announcements coincide with the designation of May as Bladder Cancer Awareness Month. The materials, made possible by funding support from Bristol Myers Squibb, feature Major League Baseball star pitcher and broadcaster, Jim Kaat. The resources offer information, help, comfort, and hope to those seeking more information about their health, and options following a diagnosis. “Nearly 68,000 people in the United States are impacted by bladder cancer every year, making it one of the most common cancers. It is also one of the deadliest cancers that will claim close to 18,000 lives in the US this year alone,” explained Dr. Michael Cookson, the President of the Society of Urologic Oncology. “Too often our patients learn about this disease upon diagnosis despite the warning signs. The resources we are sharing help patients and their caregivers navigate the best path forward for treatment and better health.” The SUO’s Guide to Advanced Bladder Cancer for Patients and Caregivers includes a 40-page guidebook and a companion (15-minute) documentary-style video. The guidebook is designed to help the reader better understand advanced bladder cancer, how it can be treated, and resources available to help improve health and well-being. Dr. Seth Lerner, a SUO physician, Chair of its Education Committee, and leader in the Bladder Cancer Advocacy Network stated, “These tools provide the information our patients, and the people who care for them need fight this disease. There are so many questions that come up along the way, and these resources will help them improve their lives in the exam room and at home too.” The video features SUO President Dr. Michael Cookson, Chair, Department of Urology, University of Oklahoma Health Sciences Center & The Stephenson Cancer Center; and Dr. Sima Porten, Associate Professor, Department of Urology, University of California, San Francisco. Also featured - speaking from the caregiver perspective - is Major League Baseball star pitcher and broadcaster Jim Kaat, who tells the moving story of his late wife’s battle with bladder cancer. “Patients and their loved ones need to understand they are not alone,” stated Dr. Sima Porten, a SUO physician and member of its Education Committee. “Having information about the disease, how it is treated, and what can be expected can provide peace of mind to those in the fight. Learning from others and sharing experiences is valuable to the physical and mental health of patients.” Additionally, public service announcements are being distributed to further promote the availability of these important resources. The thirty-second and one-minute versions of the PSA are available here: “Receiving a diagnosis of advanced bladder cancer can be scary and overwhelming. Although it might seem impossible to sift through all the new information you are faced with, SUO physicians are committed to helping our patients though treatment and trustworthy resources like this guidebook and video,” Dr. Cookson continued. The materials were produced by Conrad & Associates, an organization committed to improving health literacy by bringing together medical professionals and organizations, celebrities, and pharma to create patient education programs on current health topics. In addition to resources for patients, the materials also offer guidance for caregivers – including the personal perspective from Jim Kaat who explains, “When you’re caring for a loved one, sometimes you neglect taking care of yourself. It’s very important for the caregiver to also take care of themselves.” ### The Society of Urologic Oncology (SUO) was founded in 1984 for the purpose of bringing together healthcare professionals to discuss, develop, and implement ideas to improve care for people with malignant genitourinary diseases like bladder cancer. The SUO hosts and sponsors programs designed to provide specific expertise in urologic oncology. The SUO’s research initiatives involve clinical trials through the SUO Clinical Trials Consortium. The SUO’s primary objectives are to: Encourage research and teaching in urologic oncology Bring awareness of urologic oncology to the larger medical profession Invite urologists into a society whose work is focused in malignant disease Be the most qualified organization on matters of urologic oncology Create standards for professional training in urologic oncology Please visit For more information or to schedule an interview with a SUO spokesperson, please contact Dan Rene of kglobal at 202-329-8357 or Contact Details kglobal Dan Rene +1 202-329-8357 Company Website

May 13, 2021 02:30 PM Eastern Daylight Time

Article thumbnail News Release

LOOMIS Delivers a Dozen Awards for Texas Oncology Ad Campaign


The LOOMIS Agency delivered big for client Texas Oncology, taking home 12 awards at the 38 th Annual Healthcare Advertising Awards show, including the Gold Award for “Total Advertising Campaign.” The agency won five Gold, one Silver, four Bronze and two Merit awards for its “Right Here” campaign. “We are so pleased with the recognition,” said Steven Paulson, M.D, president and chairman of Texas Oncology. “The ‘Right Here’ campaign has been very well received by all of our stakeholders because it does a wonderful job communicating our important difference as a provider of oncology treatment and care.” Texas Oncology’s 500+ physicians deliver leading-edge cancer care at its 210 locations in communities across the state, so patients don’t have to travel far from home to receive the expert treatment they need. “That’s a big difference for Texas Oncology patients and it’s the basis of our campaign,” said LOOMIS account director Christina McKinney. “With Texas Oncology, patients don’t have to disrupt their lives to get the care they need,” McKinney said. “They can stay at home surrounded by the love and support of family and friends.” The campaign launched January 1, 2021 and is running statewide across all major media channels, including television, digital display and video, print, outdoor, search and social. There were more than 4,400 entries for this year’s Annual Healthcare Ad Awards, making it the largest healthcare advertising awards competition and placing it among the top 10 advertising awards shows in the country. About LOOMIS: LOOMIS is a full-service advertising agency in Dallas specializing in defining and leveraging strategic advantages for national and regional challenger brands. The agency was founded in 1984 by Paul Loomis, a composer and musician who earned a national reputation for brand-image music development. The agency was expanded in 1998 to meet growing client demand. Today, LOOMIS offers clients a unique blend of advertising and music production. Learn more at About Texas Oncology: Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 90 FDA-approved therapies, about one-third of all cancer therapies approved to date. For more information, visit Contact Details LOOMIS Lauren Law +1 214-912-1543 Company Website

May 13, 2021 09:15 AM Eastern Daylight Time

Video Image
1 ... 187188189190191 ... 219